-
Optiscan CEO and Chair Darren Lurie to Present at Emergence Conference in Sydney 26th – 28th February 2020
-
Optiscan visit to US Food and Drug Administration in Washington DC for InVivage® medical device in Oral Cancer
-
“..The most exciting technology that I have seen in my career come through the laboratory..”. -Mark C Preul-MD, Neurosurgeon, Barrow Neurosurgical Institute.
-
Optiscan’s East China Distributor Biotimes Showcasing Pre-Clinical FIVE2 System at the Annual Meeting of the Chinese Academy of Chinese Scholars.
-
A first look at InVivage®: Optiscan’s new oral cancer imaging device.
-
Optiscan presenter and sponsor at the BioPhotonics career workshop at Swinburne University
-
New 3D tissue culture application collaboration with CSIRO
-
Optiscan Initiates FDA Feedback for Oral Cancer 510(k) Submission
Announcements -
Optiscan Investor presentation presented by Darren Lurie at the AusBiotech Conference Melb 30th Oct – 1st Nov 2019
-
CEO Darren Lurie updates Proactive on the development of its new clinical system for oral cancer screening and surgery, on going clinical trials and new China distributor
-
Optiscan Appoints New China Distributor
Announcements -
World leading hospitals Peter Mac & US Sloan Kettering collaboration to trial Optiscan’s leading Cancer Imaging System
Announcements